COSMO Pharmaceuticals N.V. header image

COSMO Pharmaceuticals N.V.

COPN

Equity

ISIN NL0011832936 / Valor 32590356

SIX Swiss Exchange (2026-09-10)
CHF 54.80+2.05%

COSMO Pharmaceuticals N.V.
UMushroom community rating:

star star star star star
4.00 2 votes No rating yet
NegativeNeutralPositive

About company

COSMO Pharmaceuticals N.V. is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of gastrointestinal diseases. The company has successfully brought to market six approved drugs and two medical devices, addressing unmet medical needs in this therapeutic area. COSMO Pharmaceuticals is involved in the entire product lifecycle, from identifying medical needs and managing product development to obtaining regulatory approvals. The company licenses its approved products to partners with strong marketing and sales capabilities, ensuring effective market penetration. Additionally, COSMO offers a range of services related to pharmaceutical production, including the assessment of manufacturing processes, technology transfer, evaluation of product stability, market testing and release, and the preparation of necessary documentation for product registration.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-18.3%1Y
25.8%3Y
-32.3%5Y

Performance

47.3%1Y
38.0%3Y
35.9%5Y

Volatility

Market cap

1156 M

Market cap (USD)

Daily traded volume (Shares)

31,813

Daily traded volume (Shares)

1 day high/low

63.8 / 61.5

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

4.00

2 votes
Performance:
starstarstarstarstar
3.50
Innovation:
starstarstarstarstar
4.50
Society:
starstarstarstarstar
4.00
Nature:
starstarstarstarstar
4.00
Andrei Khristoliubov
UK, 21 Feb 2026
star star star star star
.
Matthew Waterhouse
UK, 19 Feb 2026
star star star star star
.

EQUITIES OF THE SAME SECTOR

Galapagos NV
Galapagos NV Galapagos NV Valor: 2130343
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.43%EUR 23.30
Orion Oyj
Orion Oyj Orion Oyj Valor: 2553367
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.25%EUR 79.00
Orion Oyj
Orion Oyj Orion Oyj Valor: 2553360
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.13%EUR 78.70
Beiersdorf AG
Beiersdorf AG Beiersdorf AG Valor: 324660
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.82%EUR 73.34
Merck KGaA
Merck KGaA Merck KGaA Valor: 412799
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.79%EUR 131.65
LivaNova PLC
LivaNova PLC LivaNova PLC Valor: 28726218
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.95%USD 78.18
Evotec SE
Evotec SE Evotec SE Valor: 505433
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.00%EUR 3.04
Draegerwerk AG & Co. KGaA
Draegerwerk AG & Co. KGaA Draegerwerk AG & Co. KGaA Valor: 330446
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.80%EUR 113.00
MEDICLIN AG
MEDICLIN AG MEDICLIN AG Valor: 1158721
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%EUR 5.55
CHAPTERS Group AG
CHAPTERS Group AG CHAPTERS Group AG Valor: 2175722
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.88%EUR 45.95